Genmab A/S
GMABNASDAQNASDAQ Global Select·USD·Closed
$32.63
−$0.72 (2.16%)
$32.63
−$0.72 (2.16%)
Not investment advice.Learn more
Genmab A/S has more going for it than against it right now.
The stock looks cheap relative to what it earns
This company doesn't pay a dividend
A big, established company. Generally lower risk
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Large-cap company
P/E Ratio
Cheap relative to earnings
Div Yield
No dividend